Table 1.
Patient characteristics and mortality in normoalbuminemic and hypoalbuminemic cardiogenic shock patients.
Table 2.
Laboratory test results and angiographic findings in normoalbuminemic and hypoalbuminemic cardiogenic shock patients.
Table 3.
Factors independently associated with hypoalbuminemia at baseline.
Fig 1.
Kaplan-Meier survival curves of 90-day mortality according to baseline plasma albumin (P-Alb).
Fig 2.
90-day mortality by baseline albumin quartiles.
The P-Alb ranges for the quartiles were 34.0–42.9 g/L for the 1st quartile, 30.0–33.9 g/L for the 2nd quartile, 25.9–29.9 g/L for the 3rd quartile and 10.4–25.9 g/L for the 4th quartile.
Table 4.
Unadjusted and adjusted odds ratios for baseline plasma albumin with 90-day mortality.
Table 5.
Comparison of cardiogenic shock risk score models.
Fig 3.
A: Mean plasma albumin at different time points during hospitalization in 90-day survivors and non-survivors of cardiogenic shock. Mean change between 0 and 72h -4.6 g/L for survivors, -5.4 g/L for non-survivors; p = 0.54. B: Plasma albumin at different time points during hospitalization in patients with normoalbuminemia or hypoalbuminemia at baseline. Mean change between 0 and 72 h -10.8 mg/L for normoalbuminemic patients and -2.5 mg/L for hypoalbuminemic patients; p<0.001. P-values in the picture represent results for linear mixed model analysis of variance for repeated measures. * p<0.05 § p<0.10 for the difference in P-Alb between groups at this time point (Student’s t-test). Error bar = standard deviation.